Fingerprint
Dive into the research topics of 'Forty days of regulatory emergency use authorisation of COVID-19 vaccines: Interfacing efficacy, hesitancy and SDG target 3.8'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Forty days of regulatory emergency use authorisation of COVID-19 vaccines: Interfacing efficacy, hesitancy and SDG target 3.8
Godwell Nhamo*, Mncengeli Sibanda
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
4
Citations
(Scopus)